Home Measurement of α-dicarbonyl compounds in human saliva by pre-column derivatization HPLC
Article
Licensed
Unlicensed Requires Authentication

Measurement of α-dicarbonyl compounds in human saliva by pre-column derivatization HPLC

  • Xin-Jie Wang , Hong-Xia Zhang , Heng Li , Ai-Hua Zhu and Wen-Yun Gao EMAIL logo
Published/Copyright: August 5, 2019
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Clinical Chemistry and Laboratory Medicine (CCLM) Volume 57 Issue 12

Abstract

Background

α-Dicarbonyl compounds (α-DCs) have been detected in body fluids including plasma and urine and elevation of this sort of compounds in vivo has been associated with the development of many kinds of chronic diseases. However whether α-DCs are present in human saliva, and if their presence/absence can be related with various chronic diseases is yet to be determined.

Methods

In this study, a pre-column derivatization HPLC-UV method was developed to measure 3-deoxyglucosone (3-DG), glyoxal (GO), methylglyoxal (MGO), diacetyl (DA), and pentane-2,3-dione (PD) in human saliva employing 4-(2,3-dimethyl-6-quinoxalinyl)-1,2-benzenediamine (DQB) as a derivatizing reagent. The derivatization of the α-DCs is fast and the conditions are facile. The method was evaluated and the results show that it is suitable for the quantification of α-DCs in human saliva.

Results

In the measurements of these α-DCs in the saliva of 15 healthy subjects and 23 type 2 diabetes mellitus (T2DM) patients, we found that the concentrations of GO and MGO in the saliva of the diabetic patients were significantly higher than those in healthy subjects. As far as we know, this is the first time that salivary α-DC concentrations have been determined and associated with T2DM.

Conclusions

The developed method would be useful for the measurement of the salivary α-DC levels and the data acquired could be informative in the early screening for diabetes.

Keywords: α-dicarbonyl compounds; diabetes; HPLC determination; saliva

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the Natural Science Foundation of China (Grants 21402152, 31770848), the Northwest University graduate independent innovation project (No. YZZ17154), and the Scientific Research Project of Shaanxi Province (No. 2017JM2027).

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Brings S, Fleming T, Freichel M, Muckenthaler MU, Herzig S, Nawroth PP. Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention. Int J Mol Sci 2017;18:984.10.3390/ijms18050984Search in Google Scholar PubMed PubMed Central

2. Henning C, Liehr K, Girndt M, Ulrich C, Glomb MA. Extending the spectrum of α-dicarbonyl compounds in vivo. J Biol Chem 2014;289:28676–88.10.1074/jbc.M114.563593Search in Google Scholar PubMed PubMed Central

3. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1–9.10.2337/diabetes.48.1.1Search in Google Scholar PubMed

4. Bilova T, Paudel G, Shilyaev N, Schmidt R, Brauch D, Tarakhovskaya E, et al. Global proteomic analysis of advanced glycation end products in the Arabidopsis proteome provides evidence for age-related glycation hotspots. J Biol Chem 2017;292:15758–76.10.1074/jbc.M117.794537Search in Google Scholar PubMed PubMed Central

5. Gobert J, Glomb MA. Degradation of glucose: reinvestigation of reactive α-dicarbonyl compounds. J Agric Food Chem 2009;57:8591–7.10.1021/jf9019085Search in Google Scholar PubMed

6. Ogawa S, Nakayama K, Nakayama M, Mori T, Matsushima M, Okamura M, et al. Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure. Hypertension 2010;56:471–6.10.1161/HYPERTENSIONAHA.110.156786Search in Google Scholar PubMed

7. Rabbani N, Thornalley PJ. Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples. Nat Protoc 2014;9:1969–79.10.1038/nprot.2014.129Search in Google Scholar PubMed

8. Scheijen JL, Schalkwijk CG. Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen. Clin Chem Lab Med 2014;52:85–91.10.1515/cclm-2012-0878Search in Google Scholar PubMed

9. Ogasawara Y, Tanaka R, Koike S, Horiuchi Y, Miyashita M, Arai M. Determination of methylglyoxal in human blood plasma using fluorescence high performance liquid chromatography after derivatization with 1,2-diamino-4,5-methylenedioxybenzene. J Chromatogr B 2016;1029–1030:102–5.10.1016/j.jchromb.2016.07.019Search in Google Scholar PubMed

10. Wang XJ, Ma SB, Liu ZF, Li H, Gao WY. Elevated levels of α-dicarbonyl compounds in the plasma of type II diabetics and their relevance with diabetic nephropathy. J Chromatogr B 2019;1106–1107:19–25.10.1016/j.jchromb.2018.12.027Search in Google Scholar PubMed

11. Hurtado-Sánchez Mdel C, Espinosa-Mansilla A, Rodríguez-Cáceres MI, Martín-Tornero E, Durán-Merás I. Development of a method for the determination of advanced glycation end products precursors by liquid chromatography and its application in human urine samples. J Sep Sci 2012;35:2575–84.10.1002/jssc.201200255Search in Google Scholar PubMed

12. Espinosa-Mansilla A, Durán-Merás I, Cañada FC, Márquez MP. High-performance liquid chromatographic determination of glyoxal and methylglyoxal in urine by prederivatization to lumazinic rings using in serial fast scan fluorimetric and diode array detectors. Anal Biochem 2007;371:82–91.10.1016/j.ab.2007.07.028Search in Google Scholar PubMed

13. Mittelmaier S, Fünfrocken M, Fenn D, Berlich R, Pischetsrieder M. Quantification of the six major α-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC/DAD/MSMS. Anal Bioanal Chem 2011;401:1183–93.10.1007/s00216-011-5195-9Search in Google Scholar PubMed

14. Buczko P, Zalewska A, Szarmach I. Saliva and oxidative stress in oral cavity and in some systemic disorders. J Physiol Pharmacol 2015;63:3–9.Search in Google Scholar

15. Malamud D. Saliva as a diagnostic fluid. Dent Clin North Am 2011;55:159–78.10.1016/j.cden.2010.08.004Search in Google Scholar PubMed PubMed Central

16. Kaufman E, Lamster IB. The diagnostic applications of saliva – a review. Crit Rev Oral Biol Med 2002;13:197–212.10.1177/154411130201300209Search in Google Scholar PubMed

17. Dator R, Carrà A, Maertens L, Guidolin V, Villalta PW, Balbo S. A high resolution/accurate mass (HRAM) data-dependent MS3 neutral loss screening, classification, and relative quantitation methodology for carbonyl compounds in saliva. J Am Soc Mass Spectrom 2017;28:608–18.10.1007/s13361-016-1521-ySearch in Google Scholar PubMed PubMed Central

18. Wang XJ, Wang JY, Li H, Hui X, Gao WY. Determination of diacetyl in liquors by high performance liquid chromatography coupled with precolumn derivatization using 3,3′-diaminobenzidine. Chin J Chromatogr 2017;35:837–42.10.3724/SP.J.1123.2017.04031Search in Google Scholar PubMed

19. Wang JY, Wang XJ, Hui X, Hua SH, Li H, Gao WY. Determination of diacetyl in beer by a pre-column derivatization-HPLC-UV method using 4-(2,3-dimethyl-6-quinoxalinyl)-1,2-benzenediamine as a derivatizing reagent. J Agric Food Chem 2017;65:2635–41.10.1021/acs.jafc.7b00990Search in Google Scholar PubMed

20. Wang XJ, Gao F, Li LC, Hui X, Li H, Gao WY. Quantitative analyses of α-dicarbonyl compounds in food samples by HPLC using 4-(2,3-dimethyl-6-quinoxalinyl)-1,2-benzenediamine as a derivatizing reagent. Microchem J 2018;141:64–70.10.1016/j.microc.2018.05.006Search in Google Scholar

21. Herold DA, Boyd JC, Bruns DE, Emerson JC, Burns KG, Bray RE, et al. Measurement of glycosylated hemoglobins using boronate affinity chromatography. Ann Clin Lab Sci 1983;13:482–8.Search in Google Scholar

22. Raabo E, Terkildsen TC. On the enzymatic determination of blood glucose. Scand J Clin Lab Invest 1960;12:402–7.10.3109/00365516009065404Search in Google Scholar PubMed

23. Nagler RM. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol 2009;45:1006–10.10.1016/j.oraloncology.2009.07.005Search in Google Scholar

24. Niwa T. 3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication. J Chromatogr B Biomed Sci Appl 1999;731:23–36.10.1016/S0378-4347(99)00113-9Search in Google Scholar

25. Khuhawar MY, Kandhro AJ, Khand FD. Liquid chromatographic determination of glyoxal and methylglyoxal from serum of diabetic patients using meso-stilbenediamine as derivatizing reagent. Anal Lett 2006;39:2205–15.10.1080/00032710600754093Search in Google Scholar

26. Nakayama K, Nakayama M, Iwabuchi M, Terawaki H, Sato T, Kohno M, et al. Plasma α-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients. Am J Nephrol 2008;28:871–8.10.1159/000139653Search in Google Scholar PubMed

27. Odani H, Shinzato T, Matsumoto Y, Usami J, Maeda K. Increase in three α,β-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun 1999;256: 89–93.10.1006/bbrc.1999.0221Search in Google Scholar PubMed

28. Lu J, Randell E, Han Y, Adeli K, Krahn J, Meng QH. Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy. Clin Biochem 2011;44:307–11.10.1016/j.clinbiochem.2010.11.004Search in Google Scholar PubMed

29. Wang B, Du J, Zhu Z, Ma Z, Wang S, Shan Z. Evaluation of parotid salivary glucose level for clinical diagnosis and monitoring type 2 diabetes mellitus patients. Biomed Res Int 2017;2017:1–5.10.1155/2017/2569707Search in Google Scholar PubMed PubMed Central

30. Darwazeh AM, MacFarlane TW, McCuish A, Lamey PJ. Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. J Oral Pathol Med 2010;20:280–3.10.1111/j.1600-0714.1991.tb00928.xSearch in Google Scholar PubMed

31. Lima-Aragão MV, de Oliveira-Junior Jde J, Maciel MC, Silva LA, do Nascimento FR, Guerra RN. Salivary profile in diabetic patients: biochemical and immunological evaluation. BMC Res Notes 2016;9:103/1–103/7.10.1186/s13104-016-1881-1Search in Google Scholar PubMed PubMed Central

32. Gupta S, Sandhu SV, Bansal H, Sharma D. Comparison of salivary and serum glucose levels in diabetic patients. J Diabetes Sci Technol 2015;9:91–6.10.1177/1932296814552673Search in Google Scholar PubMed PubMed Central

33. Mascarenhas P, Fatela B, Barahona I. Effect of diabetes mellitus type 2 on salivary glucose – a systematic review and meta-analysis of observational studies. PLoS One 2014;9:e101706.10.1371/journal.pone.0101706Search in Google Scholar PubMed PubMed Central

34. Kaufman E, Lamster IB. The diagnostic applications of saliva – a review. Crit Rev Oral Biol Med 2002;1:197–212.10.1177/154411130201300209Search in Google Scholar PubMed

35. Shangari N, Mehta R, O’brien PJ. Hepatocyte susceptibility to glyoxal is dependent on cell thiamin content. Chem Biol Interact 2007;165:146–54.10.1016/j.cbi.2006.11.009Search in Google Scholar PubMed

36. Förster A, Kühne Y, Henle T. Studies on absorption and elimination of dietary Maillard reaction products. Ann N Y Acad 2005;1043:474–81.10.1196/annals.1333.054Search in Google Scholar PubMed

Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2019-0350).

Received: 2019-01-02
Accepted: 2019-06-17
Published Online: 2019-08-05
Published in Print: 2019-11-26

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. The re-emergence of dried blood spot sampling – are we ready?
  4. Review
  5. The role of platelets in bleeding in patients with thrombocytopenia and hematological disease
  6. Opinion Paper
  7. Exertional hematuria: definition, epidemiology, diagnostic and clinical considerations
  8. Guidelines and Recommendations from Scientific Societies
  9. A protocol for testing the stability of biochemical analytes. Technical document
  10. Genetics and Molecular Diagnostics
  11. Hereditary hyperferritinaemia-cataract syndrome (HHCS) – an underestimated condition: ferritin light chain variant spectrum in German families
  12. General Clinical Chemistry and Laboratory Medicine
  13. Performance of a web-based application measuring spot quality in dried blood spot sampling
  14. Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients
  15. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study
  16. Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer’s disease
  17. Integrity of serum samples is changed by modified centrifugation conditions
  18. Heparin and citrate additive carryover during blood collection
  19. Copeptin – a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease
  20. Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits
  21. Measurement of α-dicarbonyl compounds in human saliva by pre-column derivatization HPLC
  22. Establishment of the intelligent verification criteria for a routine urinalysis analyzer in a multi-center study
  23. Reference Values and Biological Variations
  24. A new indirect estimation of reference intervals: truncated minimum chi-square (TMC) approach
  25. EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency
  26. Early pregnancy reference intervals; 29 serum analytes from 4 to 12 weeks’ gestation in naturally conceived and uncomplicated pregnancies resulting in live births
  27. Paediatric reference intervals for 17 Roche cobas 8000 e602 immunoassays in the CALIPER cohort of healthy children and adolescents
  28. Hematology and Coagulation
  29. Study of the analytical performance at different concentrations of hematological parameters using Spanish EQAS data
  30. Multicenter performance evaluation of the Abbott Alinity hq hematology analyzer
  31. Cardiovascular Diseases
  32. Fast 0/1-h algorithm for detection of NSTEMI: are current high-sensitivity cardiac troponin assays fit for purpose? An EQA-based evaluation
  33. Infectious Diseases
  34. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis – a pilot study
  35. Letters to the Editor
  36. Quality management at the national biobanking level – establishing a culture of mutual trust and support: the BBMRI.at example
  37. Molecular diagnosis of MODY3 permitted to reveal a de novo 12q24.31 deletion and to explain a complex phenotype in a young diabetic patient
  38. Increased C-reactive protein values in the absence of inflammation: monoclonal immunoglobulin interference in immunonephelometry
  39. An approach based on simulated hemolysis for establishing the hemolysis index threshold for high-sensitivity cardiac troponin T assay
  40. Utility of the icteric index for the management of bilirubin test requesting
  41. Quality control of monocyte volume and distribution width parameters of the Beckman Coulter DxH series
  42. Mozhaisk haemoglobin variant effects on leukocyte differential channel using the Sysmex XN series
  43. Detection of a novel hemoglobin variant Hb Liaoning by matrix assisted laser desorption/ionization-time of flight mass spectrometry
  44. Appropriateness of repetitive therapeutic drug monitoring and laboratory turnaround time
  45. Congress Abstracts
  46. 51th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
https://doi.org/10.1515/cclm-2019-0350
Keywords for this article
α-dicarbonyl compounds; diabetes; HPLC determination; saliva

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. The re-emergence of dried blood spot sampling – are we ready?
  4. Review
  5. The role of platelets in bleeding in patients with thrombocytopenia and hematological disease
  6. Opinion Paper
  7. Exertional hematuria: definition, epidemiology, diagnostic and clinical considerations
  8. Guidelines and Recommendations from Scientific Societies
  9. A protocol for testing the stability of biochemical analytes. Technical document
  10. Genetics and Molecular Diagnostics
  11. Hereditary hyperferritinaemia-cataract syndrome (HHCS) – an underestimated condition: ferritin light chain variant spectrum in German families
  12. General Clinical Chemistry and Laboratory Medicine
  13. Performance of a web-based application measuring spot quality in dried blood spot sampling
  14. Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients
  15. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study
  16. Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer’s disease
  17. Integrity of serum samples is changed by modified centrifugation conditions
  18. Heparin and citrate additive carryover during blood collection
  19. Copeptin – a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease
  20. Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits
  21. Measurement of α-dicarbonyl compounds in human saliva by pre-column derivatization HPLC
  22. Establishment of the intelligent verification criteria for a routine urinalysis analyzer in a multi-center study
  23. Reference Values and Biological Variations
  24. A new indirect estimation of reference intervals: truncated minimum chi-square (TMC) approach
  25. EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency
  26. Early pregnancy reference intervals; 29 serum analytes from 4 to 12 weeks’ gestation in naturally conceived and uncomplicated pregnancies resulting in live births
  27. Paediatric reference intervals for 17 Roche cobas 8000 e602 immunoassays in the CALIPER cohort of healthy children and adolescents
  28. Hematology and Coagulation
  29. Study of the analytical performance at different concentrations of hematological parameters using Spanish EQAS data
  30. Multicenter performance evaluation of the Abbott Alinity hq hematology analyzer
  31. Cardiovascular Diseases
  32. Fast 0/1-h algorithm for detection of NSTEMI: are current high-sensitivity cardiac troponin assays fit for purpose? An EQA-based evaluation
  33. Infectious Diseases
  34. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis – a pilot study
  35. Letters to the Editor
  36. Quality management at the national biobanking level – establishing a culture of mutual trust and support: the BBMRI.at example
  37. Molecular diagnosis of MODY3 permitted to reveal a de novo 12q24.31 deletion and to explain a complex phenotype in a young diabetic patient
  38. Increased C-reactive protein values in the absence of inflammation: monoclonal immunoglobulin interference in immunonephelometry
  39. An approach based on simulated hemolysis for establishing the hemolysis index threshold for high-sensitivity cardiac troponin T assay
  40. Utility of the icteric index for the management of bilirubin test requesting
  41. Quality control of monocyte volume and distribution width parameters of the Beckman Coulter DxH series
  42. Mozhaisk haemoglobin variant effects on leukocyte differential channel using the Sysmex XN series
  43. Detection of a novel hemoglobin variant Hb Liaoning by matrix assisted laser desorption/ionization-time of flight mass spectrometry
  44. Appropriateness of repetitive therapeutic drug monitoring and laboratory turnaround time
  45. Congress Abstracts
  46. 51th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2019-0350/html?lang=en
Scroll to top button